Skip to main content
Download PDF

Participation of COX2/mPGES1/PGE2 in mouse and human endometrial stromal decidualization

BMC Veterinary Research volume 21, Article number: 43 (2025) Cite this article

Abstract

Background

Prostaglandin E2 (PGE2) is vital for embryo implantation and decidualization. Whether COX2/mPGES1/PGE2 pathway is essential for mouse and human decidualization remains unclear.

Results

This study showed that mPGES1 was highly expressed in the mouse uterus’s subluminal stromal cells at the implantation site. COX2-specific inhibitor Valdecoxib and mPGES1 selective inhibitor MK886 were used to analyze the roles of mPGES1 and COX2 during mouse and human decidualization. During mouse in vitro decidualization, decidua/trophoblast prolactin-related protein (Dtprp) expression was significantly suppressed by Valdecoxib and MK886. Under human in vitro decidualization, mPGES1 significantly increases, while both cPGES and mPGES2 remain unchanged. PGE2-mediated upregulation of insulin growth factor binding protein 1 (IGFBP1) was significantly inhibited by Valdecoxib and MK886.

Conclusions

Our findings suggest the involvement of COX2/mPGES1/PGE2 pathway in both mouse and human decidualization.

Peer Review reports

Background

Embryo implantation is a crucial process in pregnancy. The failure of embryo implantation is a major cause of early pregnancy loss before it is clinically recognized. Synchronization between receptive endometrium and blastocyst competency is consequential for implantation [1]. In the mouse, both PGE2 and prostacyclin I2 (PGI2) are involved in implantation and decidualization [2, 3]. In rats, PGE2 is a crucial mediator of increased vascular permeability at the implantation site [4]. PGE2 has also been shown to be essential during hamster implantation [5]. Analysis of the lipidomic profile in the human endometrial fluid shows that PGE2 and PGF2α concentrations increase significantly during the window of implantation in natural cycles [6]. During mouse embryo implantation, PGE2 is also a key mediator for activating the epithelial Na+ channel; blocking the activation of the epithelial Na+ channel will lead to embryo implantation failure [7]. Deficiency of lysophosphatidic acid receptor 3 (LPA3) in mice results in significantly reduced litter size and alteration of embryo spacing. Although the exogenous administration of PGE2 or carboprostacyclin (a stable analog of PGI2) into LPA3-deficient female mice can rescue delayed implantation, it does not rescue defects in embryo spacing [8].

PGH2 is generated from the COX2 conversion of arachidonic acid, and it is metabolized to PGE2 by prostaglandin E2 synthases (PGESs) [9]. There are three isoforms of PGESs: microsomal PGES1 (mPGES1, PTGES1), mPGES2 (PTGES2), and cytosolic PGES (cPGES, PTGES3) [10]. mPGES1 is an inducible perinuclear enzyme preferentially coupled with the inducible COX2 to promote PGE2 generation [11, 12] that is strongly expressed at the implantation site in the mouse uterus [2]. In the monkey’s endometrium, COX2 and mPGES1 are strongly detected in the mid-luteal phase of the menstrual cycle [13]. In humans, increased expression of mPGES1 mRNA has been detected in most of the endometriosis samples [14]. Although mPGES1 is a crucial enzyme for producing PGE2, expressed explicitly on the implantation site on day 5 in mice, its role during mouse and human decidualization remains unclear.

MK886 is a specific inhibitor of mPGES1 and has no significant effects on mPGES2 and cPGES [15]. Valdecoxib can selectively inhibit COX2 expression [16]. In this study, MK886 and Valdecoxib were applied to examine the roles of mPGES1 and COX2 during mouse and human in vitro decidualization, respectively. Both mice and human in vitro decidualization were significantly suppressed by MK886 and Valdecoxib.

Results

Expression of mPGES1 in mouse uterus during early pregnancy

The RNA in situ hybridization results demonstrated that mPGES1 mRNA was highly expressed in the subluminal stromal cells at the implantation site compared to the inter-implantation site in mice (Fig. 1A). Real-time PCR showed that, compared to inter-implantation sites, mPGES1 mRNA level was upregulated at implantation sites in mice (P = 0.0181) (Fig. 1B).

Fig. 1
figure 1

mPGES1 expression in mouse uterus at implantation site on day 5 of pregnancy. (A) In situ hybridization of mPGES1 mRNA expression; D5 NI, non-implantation site (n = 3); D5 I or D5 IS, implantation site (n = 3); D5 Con, negative control (n = 3). Scale bar = 300 μm. (B) Real-time PCR analysis of mPGES1 mRNA levels in mouse uterus on day 5 of pregnancy (n = 3). Data were normalized with Rpl7. *P < 0.05

Full size image

Effects of MK886 and Valdecoxib on mouse in vitro decidualization

We explored the role of COX2 and mPGES1 in decidualization through the use of inhibitors. Under in vitro decidualization of induction with progesterone and estradiol-17β, the expression of Dtprp was attenuated by MK886 and Valdecoxib in a dose-dependent manner (Fig. 2A and B).

Fig. 2
figure 2

Effects of MK886 and Valdecoxib on mouse in vitro decidualization. (A) Effects of MK886 on mouse in vitro decidualization. (B) Effects of Valdecoxib on mouse in vitro decidualization. Mouse endometrial stromal cells were co-treated with estradiol-17β and progesterone (E + P) to induce in vitro decidualization. Dtprp level, a marker of mouse in vitro decidualization, was significantly inhibited by MK886 and Valdecoxib(n = 3). Data were normalized with Rpl7. *P < 0.05

Full size image

Expression and role of PGES during human in vitro decidualization

Our results showed that when human endometrial stromal cells were induced for in vitro decidualization, mPGES1 was significantly stimulated; however, the levels of cPGES and mPGES2 were unaffected (Fig. 3A-C). The expression of IGFBP1 was significantly increased after in vitro decidualization of human endometrial stromal cells (Fig. 3D and E). When human stromal cells were treated with MK886 after in vitro decidualization, the IGFBP1 level was reduced (Fig. 3D). Furthermore, IGFBP1 expression was decreased by Valdecoxib under in vitro decidualization (Fig. 3E).

Fig. 3
figure 3

Expression and function of prostaglandin synthases during human in vitro decidualization. (A)mPGES1 expression. (B)cPGES expression. (C)mPGES2 expression. (D) Effects of MK886 on human in vitro decidualization. (E) Effects of Valdecoxib on human in vitro decidualization. Human endometrium stromal cells were induced for in vitro decidualization by MPA and db-cAMP for 6 days. Cells were treated with DMSO as the control. IGFBP1 expression was significantly inhibited by 5 and 10 μM of MK886 or Valdecoxib, respectively(n = 3). Data were normalized with RPL7. *P < 0.05

Full size image

Effects of MK886 and Valdecoxib on PGE2-induced in vitro decidualization in human endometrial stromal cells

Treating human endometrial stromal cells with PGE2 upregulated IGFBP1 expression (Fig. 4A). PGE2-induced IGFBP1 expression was abrogated by MK886 (Fig. 4A) and Valdecoxib (Fig. 4B). Moreover, MK886 and Valdecoxib reduced IGFBP1 and were rescued by PGE2 (Fig. 4C and D).

Fig. 4
figure 4

Effects of MK886 and Valdecoxib on PGE2-induced IGFBP1 expression in human endometrium stromal cells. (A) Effects of MK886 on PGE2-induced IGFBP1 expression. (B) Effects of Valdecoxib on PGE2-induced IGFBP1 expression. (C) Effects of PGE2 on MK886-abolished IGFBP1 expression. (D) Effects of PGE2 on Valdecoxib-abolished IGFBP1 expression(n = 3). Data were normalized with RPL7. *P < 0.05

Full size image

Discussion

In this study, our in situ hybridization assay showed the localization of mPGES1 was increased in the mouse implantation site. This result was similar to a previous study [2]. mPGES1 is also strongly detected at implantation sites in rat and hamster uteri [5, 17]. It has been shown that the coculture of human endometrial stromal cells with first-trimester trophoblast explants causes an increase in mPGES1 [18]. Although PGES expression in human endometrium is unknown, our data suggests that mPGES1 is the predominant PGES expressed during human in vitro decidualization. In vitro decidualization in mice and humans is inhibited by MK886, a specific inhibitor for mPGES1. These data suggest that mPGES1 should play a key role during mammalian decidualization.

mPGES1 is the terminal synthase for synthesizing PGE2 from COX2-derived PGH2 [10]. PGE2 and PGF2α are two major markers highly represented in endometrial fluid at the receptive phase during the human menstrual cycle [6]. PGE2 is also used to rescue the abnormalities of embryo implantation in LPA3-deficient mice [8]. During embryo implantation, PGE2 mediates the trypsin activation of the epithelial Na+ channel [7]. PGE2 stimulates chemokines to enhance embryo development and adhesion to the maternal decidua [19]. Conversely, PGE2 insufficiency causes failure in implantation and decidualization [20]. Furthermore, intrauterine administration of PGE2 can induce decidualization in rats [21]. In our study, PGE2 also significantly stimulated the expression of IGFBP1 in human endometrial stromal cells, which was abolished by MK886. Therefore, PGE2 was involved in human endometrial stromal cell decidualization.

As the rate-limiting enzyme in the production of prostaglandins, COX2 plays an essential role during early pregnancy, including fertilization and embryo development [22]. COX2 is strongly expressed at implantation sites in day 5 pregnant mouse uterus [23], which is also co-localized with mPGES1 expression [2]. COX2-deficient females are infertile with abnormalities in ovulation, fertilization, implantation, and decidualization [24]. Our study suggested that the COX2-specific inhibitor Valdecoxib significantly inhibited the mouse and human in vitro decidualization. It is possible that COX2 and mPGES1 are essential for mouse and human decidualization.

Conclusions

This study showed that mPGES-1, the terminal synthase for synthesizing PGE2 from COX2-derived PGH2, is highly expressed in the stroma cells surrounding the embryo on day 5 of pregnancy. Both COX2 and mPGES1 inhibitors blocked the process of in vitro decidualization in the mouse or human endometrial stromal cells. Our results demonstrated that COX2/mPGES1/PGE2 pathway may participate in mouse and human endometrial stromal decidualization.

Methods

Animal treatments

This study was approved by the Institutional Animal Care and Use Committee of Shanxi Agricultural University. Mature mice (CD-1 strain, 6 weeks old) were purchased from Hunan Slack Laboratory Animal Co., LTD and maintained in a temperature (22 ℃) and light (12 h light and 12 h dark) controlled SPF environment. Female mice were mated with fertile CD1 males to induce pregnancy (day 1 = vaginal plug). To identify the implantation sites on day 5 of pregnancy, animals were injected with 100 μL of 1% Chicago sky blue (Sigma-Aldrich, St. Louis, MO, USA) via the tail vein and euthanized by cervical dislocation after 5 min. Samples of implantation site (IS) and non-implantation site (NI) were collected from the uterus on day 5 of pregnancy and stored at -80 ℃ for in situ hybridization (n = 5 mice) and real-time PCR analysis (n = 5 mice).

In situ hybridization

In situ hybridization was performed as previously described [2]. Shortly, frozen mice sections of uterine implantation and non-implantation sites (10 μm, cut by Leica CM1860 and stored at -80 ℃), mounted on the APES (3-Aminopropyl-Triethoxysilane, Sigma-Aldrich)-pretreated glass slides, were fixed with paraformaldehyde in PBS and rinsed with 1% Triton X-100. Sections were then prehybridized at room temperature and hybridized with the mPGES-1 antisense probe overnight at 55℃. Sections were washed with buffers and incubated with alkaline phosphatase-conjugated anti-DIG (Digoxin) antibody (Roche Applied Science) diluted in blocking solution (1:5000) overnight at 4℃. Finally, signals were detected by 5-Bromo-4-Chloro-3-Indolyl Phosphate (Sigma-Aldrich) and nitroblue tetrazolium (Sigma-Aldrich). Besides, levamisole (Sigma-Aldrich) was used as an endogenous alkaline phosphatase inhibitor to reduce background alkaline phosphatase activity.

Isolation and treatment of mouse uterine stromal cells

Mouse endometrial stromal cells were enzymatically isolated from mouse uteri on day 4 of pregnancy [25]. Briefly, uteri were removed soon after the euthanasia, split longitudinally, and digested in 5 mL of Hanks’ balanced salt solution (HBSS, Sigma-Aldrich) containing 6 mg/mL dispase (Roche, Indianapolis, IN) and 1% trypsin (Amresco, Solon, OH) for 1 h at 4℃, then 1 h at 22℃ and 10 min at 37℃. Uteri were treated with 0.15 mg/mL collagenase I (Invitrogen, Carlsbad, CA) with HBSS at 37℃ for 30 min after dislodging epithelial fragments. Then, the endometrial stroma was shaken 20 to 30 times. The supernatant was centrifuged for 5 min at a speed of 1200 rpm. Cell pellets were washed once and re-suspended in DMEM/F12 (Sigma-Aldrich) containing 10% fetal bovine serum (FBS, Gibco Life Technologies, Grand Island, NY, USA). Cells were plated onto culture dishes. The medium was changed to remove free-floating cells after an initial culture for 6 h.

Mouse endometrial stromal cells were induced for in vitro decidualization with 1 μM of progesterone (P4, Sigma-Aldrich) and 10 nM of estradiol-17β for 48 h (E2, Sigma-Aldrich) as previously described [26]; a control group was treated with ethanol.

The cell viability assay

To measure cell viability, stromal cells were seeded onto 96-well plates and treated by MK886 (0, 5, 15, 25, and 50 μM) for 2 days or 6 days and incubated with reagents from Cell Counting Kit-8 (Sigma-Aldrich) for 4 h. Afterward, the spectrometric absorbance was assessed at 450 nm. The viability rate was calculated as the sample’s (MK886 5, 15, 20, 50 μM) OD value divided by the control’s (MK886 0 μM) average OD value. The cell viability was unaffected until MK886 was over 25μM in mouse uterine stromal cells (Figure S1 A) and human stromal cells (Figure S1 B).

Culture and treatment of human endometrial stromal cells

Immortalized human endometrial stromal cell line (ATCC, CRL-4003™) was used in this study. Frozen cells were revived and cultured with DMEM/F12 containing 10% charcoal-treated FBS (cFBS, Biological Industries, Cromwell, Israel) at 37 °C with 5% CO2. Cells were plated at a density of 3 × 105 per well for each treatment in 12-well plates.

To induce in vitro decidualization, human endometrial stromal cells were treated with 500 μM db-cAMP (Sigma-Aldrich) and 1 μM medroxyprogesterone acetate (MPA, Sigma-Aldrich) for 6 days as previously described [27], the control group was treated with 0.1% (V/V) ethanol with the same time. IGFBP1, a marker of human in vitro decidualization [28], was used in this study.

COX2-specific inhibitor Valdecoxib (0, 5, and 10 μM), mPGES1 selective inhibitor MK886 (0, 5, and 10 μM), or PGE2 (5, 10, and 20 μM) were treated for 6 days with or without in vitro decidualization [29]. Each treatment group contained 3-well cells treated as described above, and at least 3 independent replication experiments were performed.

RNA extraction and real-time PCR

Quantitative real-time PCR (real-time PCR) was performed to analyze the differential expression of each gene. This experiment used the Trizol Kit (Sigma-Aldrich) to extract total RNAs. RNA integrity was checked with agarose gel electrophoresis. Then, the RNAs (500 ng) were reverse transcribed into cDNAs using the PrimeScript reverse transcriptase reagent kit (TaKaRa, Tokyo, Japan). The cDNAs were amplified using the SYBR Premix Ex Taq kit (TaKaRa; DRR041S) on the CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). The 2−∆∆CT analysis method was used to determine relative fold changes of gene expression compared with Rpl7 in mice and humans. The sequences of primers used for real-time PCR are listed in Table 1.

Table 1 Primers used in this study
Full size table

Statistical analysis

All results shown are representative of at least three independent experiments for the in vitro study. Data were presented as the mean ± standard deviation and were analyzed using the student’s t-test for two groups. A one-way ANOVA test was performed for multiple comparisons. Significance was set at P < 0.05.

Data availability

All data generated or analyzed during this study are included in this published article.

Abbreviations

Dtprp:

Decidua/trophoblast prolactin-related protein

IGFBP1:

Insulin growth factor binding protein 1

LPA3:

Lysophosphatidic acid receptor 3

PGE2:

Prostaglandin E2

PGI2:

Prostacyclin I2

References

  1. Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006;7(3):185–99.

    Article  PubMed  Google Scholar 

  2. Ni H, Sun T, Ding N-Z, Ma X-H, Yang Z-M. Differential expression of microsomal prostaglandin e synthase at implantation sites and in decidual cells of mouse uterus. Biol Reprod. 2002;67(1):351–8.

    Article  CAS  PubMed  Google Scholar 

  3. Lim H, Gupta RA, Ma W-g, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM, Dey SK. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 1999;13(12):1561–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kennedy T. Prostaglandins and increased endometrial vascular permeability resulting from the application of an artificial stimulus to the uterus of the rat sensitized for the decidual cell reaction. Biol Reprod. 1979;20(3):560–6.

    Article  CAS  PubMed  Google Scholar 

  5. Wang X, Su Y, Deb K, Raposo M, Morrow JD, Reese J, Paria BC. Prostaglandin E2 is a product of induced prostaglandin-endoperoxide synthase 2 and microsomal-type prostaglandin E synthase at the implantation site of the hamster. J Biol Chem. 2004;279(29):30579–87.

    Article  CAS  PubMed  Google Scholar 

  6. Vilella F, Ramirez L, Berlanga O, Martínez S, Alamá P, Meseguer M, Pellicer A, Simón CJTJoCE. Metabolism: PGE2 and PGF2α concentrations in human endometrial fluid as biomarkers for embryonic implantation. J Clin Endocrinol Metab. 2013;98(10):4123–4132.

  7. Ruan YC, Guo JH, Liu X, Zhang R, Tsang LL, Da Dong J, Chen H, Yu MK, Jiang X, Zhang XH. Activation of the epithelial na + channel triggers prostaglandin E2 release and production required for embryo implantation. Nat Med. 2012;18(7):1112–7.

    Article  CAS  PubMed  Google Scholar 

  8. Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T, Kennedy G, Arai H. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature. 2005;435(7038):104–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Finetti F, Paradisi L, Bernardi C, Pannini M, Trabalzini L. Cooperation between Prostaglandin E2 and epidermal growth factor receptor in cancer progression: a dual target for cancer therapy. Cancers. 2023;15(8):2374.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Murakami M, Nakatani Y, Tanioka T, Kudo I. Prostaglandin E synthase. Prostaglandins Other Lipid Mediat. 2002;68:383–99.

    Article  PubMed  Google Scholar 

  11. Jakobsson P-J, Thorén S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci. 1999;96(13):7220–7225.

  12. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, Ikeda T, Fueki M, Ueno A, Oh-ishi S. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem. 2000;275(42):32783–92.

    Article  CAS  PubMed  Google Scholar 

  13. Sun T, Li S-J, Diao H-L, Teng C-B, Wang H-B, Yang Z-M. Cyclooxygenases and prostaglandin E synthases in the endometrium of the rhesus monkey during the menstrual cycle. Reproduction. 2004;127(4):465–73.

    Article  CAS  PubMed  Google Scholar 

  14. Chishima F, Hayakawa S, Yamamoto T, Sugitani M, Karasaki-Suzuki M, Sugita K, Nemoto N. Expression of inducible microsomal prostaglandin E synthase in local lesions of endometriosis patients. Am J Reprod Immunol. 2007;57(3):218–26.

    Article  CAS  PubMed  Google Scholar 

  15. Riendeau D, Aspiotis R, Ethier D, Gareau Y, Grimm EL, Guay J, Guiral S, Juteau H, Mancini JA, Méthot N. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886. Bioorg Med Chem Lett. 2005;15(14):3352–5.

    Article  CAS  PubMed  Google Scholar 

  16. Park SY, Cho W, El-Aty AMA, Hacimuftuoglu A, Jeong JH, Jung TW. Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress. Biochem Pharmacol. 2022;199:115022.

    Article  CAS  PubMed  Google Scholar 

  17. Cong J, Diao H-L, Zhao Y-C, Ni H, Yan Y-Q, Yang Z-M. Differential expression and regulation of cylooxygenases, prostaglandin E synthases and prostacyclin synthase in rat uterus during the peri-implantation period. Reproduction. 2006;131(1):139–51.

    Article  CAS  PubMed  Google Scholar 

  18. Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, Bloethner S, Schlotterer A, Kumar R, Strowitzki T. Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology. 2006;147(12):5662–75.

    Article  CAS  PubMed  Google Scholar 

  19. Niringiyumukiza JD, Cai H, Xiang W. Prostaglandin E2 involvement in mammalian female fertility: ovulation, fertilization, embryo development and early implantation. Reproductive Biology Endocrinol. 2018;16(1):43.

    Article  Google Scholar 

  20. Mayoral Andrade G, Vásquez Martínez G, Pérez-Campos Mayoral L, Hernández-Huerta M, Zenteno E, Pérez-Campos Mayoral E, Martínez Cruz M, Martínez Cruz R, Matias-Cervantes C, Meraz Cruz N, et al. Molecules and prostaglandins related to embryo tolerance. Front Immunol. 2020;11:555414.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kennedy TG, Gillio-Meina C, Phang SH. Prostaglandins and the initiation of blastocyst implantation and decidualization. Reproduction. 2007;134(5):635–43.

    Article  CAS  PubMed  Google Scholar 

  22. Anamthathmakula P, Winuthayanon W. Prostaglandin-endoperoxide synthase 2 (PTGS2) in the oviduct: roles in fertilization and early embryo development. Endocrinology. 2021;162(4):bqab025.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Chakraborty J, Das S, Wang J, Dey S. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol. 1996;16:107–22.

    Article  CAS  PubMed  Google Scholar 

  24. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. Multiple female reproductive failures in cyclooxygenase 2–deficient mice. Cell. 1997;91(2):197–208.

    Article  CAS  PubMed  Google Scholar 

  25. Hu S-J, Ren G, Liu J-L, Zhao Z-A, Yu Y-S, Su R-W, Ma X-H, Ni H, Lei W. Yang Z-M: MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem. 2008;283(34):23473–84.

    Article  CAS  PubMed  Google Scholar 

  26. Lei W, Feng X-H, Deng W-B, Ni H, Zhang Z-R, Jia B, Yang X-L, Wang T-S, Liu J-L, Su R-W. Progesterone and DNA damage encourage uterine cell proliferation and decidualization through up-regulating ribonucleotide reductase 2 expression during early pregnancy in mice. J Biol Chem. 2012;287(19):15174–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Qi Q-R, Zhao X-Y, Zuo R-J, Wang T-S, Gu X-W, Liu J-L, Yang Z-M. Involvement of atypical transcription factor E2F8 in the polyploidization during mouse and human decidualization. Cell Cycle. 2015;14(12):1842–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wang P-C, Chen S-T, Hong Z-K, Li S-Y, Yang Z-S, Quan S, Yang Z-M. Ryptophan and kynurenine stimulate human decidualization via activating Aryl hydrocarbon receptor: short title: kynurenine action on human decidualization. Reprod Toxicol. 2020;96:282–92.

    Article  CAS  PubMed  Google Scholar 

  29. Fu T, Zheng HT, Zhang HY, Chen ZC, Li B, Yang ZM. Oncostatin M expression in the mouse uterus during early pregnancy promotes embryo implantation and decidualization. FEBS Lett. 2019;593(15):2040–50.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to express our deep appreciation and gratitude to the University Science and Technology Innovation Project of the Shanxi Province (Grant No.2021L170), Fundamental Research Program of Shanxi Province (Grant No. 202203021222172). Shanxi Province Excellent Doctoral Work Award-Scientific Research Project (Grant No. SXBYKY2021040 and SXBYKY2022013) and the Science and Technology Innovation Program of Shanxi Agricultural University (Grant No.2021BQ05).

Funding

This work was supported by the University Science and Technology Innovation Project of the Shanxi Province (Grant No.2021L170), Fundamental Research Program of Shanxi Province (Grant No. 202203021222172). Shanxi Province Excellent Doctoral Work Award-Scientific Research Project (Grant No. SXBYKY2021040 and SXBYKY2022013) and the Science and Technology Innovation Program of Shanxi Agricultural University (Grant No.2021BQ05).

Author information

Author notes

  1. Peng-Chao Wang and Jie Liu contributed equally to this work.

Authors and Affiliations

  1. College of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Jinzhong, China

    Peng-Chao Wang

  2. Dakewe Biotech Co., Ltd., Guangzhou, 510642, China

    Jie Liu

  3. Department of Cell Biology, Zunyi Medical University, Zunyi, 563099, Guizhou, China

    Yue-Fang Liu

  4. Department of Reproductive Medicine, Sichuan Provincial Maternity and Child Health Care Hospital, Chengdu, 610045, China

    Yang Wu

  5. Department of Basic Science, Shanxi Agricultural University, Taigu, 030801, Jinzhong, China

    Lin-Li Xue

  6. Division of Oncology, Department of Clinical Sciences, Lund University, Lund, 22381, Sweden

    Zhen-Shan Yang

Authors
  1. Peng-Chao Wang
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Jie Liu
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Yue-Fang Liu
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Yang Wu
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Lin-Li Xue
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Zhen-Shan Yang
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

Peng-Chao Wang: Conceptualization, Methodology, Data curation, Writing- Original draft preparation, Investigation, Writing- Reviewing and Editing; Jie Liu: Data curation, Investigation, Writing- Original draft preparation and editing; Yue-Fang Liu: Writing- Original draft preparation and Editing; Yang Wu: Data curation, Investigation, Writing- Original draft preparation and editing; Zhen-Shan Yang: Writing- Original draft preparation, Writing -review & editing, Supervision; Lin-Li Xue: Conceptualization, Supervision, Writing-review & editing.

Corresponding author

Correspondence to Lin-Li Xue.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Institutional Animal Care and Use Committee of Shanxi Agricultural University. All mouse protocols were approved by the Institutional Animal Care and Use Committee of Shanxi Agricultural University. All methods were carried out in accordance with ARRIVE guidelines. The animals used in this study were derived from commercial sources, and the owners’ consent was not required.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, PC., Liu, J., Liu, YF. et al. Participation of COX2/mPGES1/PGE2 in mouse and human endometrial stromal decidualization. BMC Vet Res 21, 43 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12917-025-04505-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12917-025-04505-5

Keywords

BMC Veterinary Research

ISSN: 1746-6148

Contact us